脑微出血对tau相关认知与结构衰退的影响
本研究为纵向前瞻性队列,纳入201名轻度认知障碍、阿尔茨海默病痴呆或认知正常者,基线行Aβ与tau PET及MRI,每年认知评估、2年复查MRI。结果显示tau负荷仅在不伴脑微出血组与认知下降和皮质萎缩相关,伴微出血组进展更多由CSVD等非tau机制解释。
要点
- 脑微出血可修饰tau负荷与认知下降的关联,交互作用显著。
- 伴微出血者CSVD负担更重,神经退行性变不完全由tau解释。
- 解读tau PET预后意义时需结合脑微出血状态。
核心结论
- 在不伴脑微出血组,基线tau负荷与CDR-SOB进展、MMSE下降及广泛皮质萎缩相关。
- 伴脑微出血组tau与认知下降的关联不显著,疾病进展可能涉及CSVD或神经炎症等额外机制。
研究设计与样本
- 纵向前瞻性队列研究,纳入201名参与者(平均年龄71.3±7.0岁,66.7%女性),其中95例有脑微出血、106例无。
- 参与者来自单中心记忆障碍门诊的轻度认知障碍或阿尔茨海默病痴呆患者,以及社区认知正常者。
- 基线完成认知评估、MRI、18F-flutemetamol PET测Aβ及18F-MK-6240 PET测tau,认知每年评估、MRI 2年复查。
主要发现
- 两组基线Aβ或tau负担无显著差异,但脑微出血组白质高信号体积和腔隙灶更多。
- 横断面上,两组中tau负荷越高均与CDR-SOB或MMSE认知评分越差相关。
- 纵向上,基线tau负荷与非脑微出血组CDR-SOB进展相关(β=1.558,SE=0.249,p<0.001),与脑微出血组无关(β=-0.031,SE=0.405,p=0.940;交互p=0.001)。
- MMSE变化呈相似组间差异(非脑微出血组β=-2.365,SE=0.566,p<0.001;脑微出血组β=-0.816,SE=0.653,p=0.217;交互p=0.073)。
- 按脑叶微出血分层,CDR-SOB(交互p=0.007)和MMSE(交互p=0.045)交互效应均显著;tau相关皮质萎缩仅在不伴脑微出血组广泛存在。
临床怎么用
- 对伴脑微出血的认知障碍患者,不应仅凭tau负荷预判认知下降速度。
- 评估脑微出血及CSVD负担有助于识别tau以外驱动神经退行性变的机制。
局限性
- 单中心研究,样本量201例,结果外推需谨慎。
- 随访期间认知每年评估、MRI仅2年复查,长期动态未覆盖。
- 脑微出血组进展机制为推测性解释,未直接验证CSVD或神经炎症通路。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: Cognitive impairment in older adults is influenced by coexisting β-amyloid (Aβ), tau, and cerebral small vessel disease (CSVD). Cerebral microbleeds (CMBs) are associated with Aβ and CSVD, but their role on tau-related neurodegeneration remains unclear. We investigated whether the CMBs modify tau-related disease progression. METHODS: A longitudinal, prospective cohort study was conducted involving participants with mild cognitive impairment, Alzheimer disease dementia from the memory disorder clinic of the single tertiary center, or cognitively unimpaired from the community. All participants underwent cognitive assessment, MRI, 18F-flutemetamol PET for Aβ, and 18F-MK-6240 PET for tau at baseline. Cognitive tests were performed annually and MRI at 2 years. Cognitive decline was defined by score changes over this period and cortical atrophy as annual cortical thickness change. Linear regression analyses were conducted after stratifying by total or lobar CMB presence. RESULTS: Among the 201 participants (mean age 71.3 ± 7.0 years, 66.7% female), 95 had CMBs and 106 did not. Baseline Aβ or tau burden did not significantly differ between the 2 groups while white matter hyperintensity volume and lacunes were greater in the CMB group. Cross-sectionally, greater tau burden correlated with worse cognition, as measured by the Clinical Dementia Rating Scale Sum of Boxes (CDR-SOB) or Mini-Mental State Examination (MMSE) in both groups. Longitudinally, baseline tau burden was associated with CDR-SOB progression in the non-CMB group (β = 1.558, SE = 0.249, p < 0.001), but not in the CMB group (β = -0.031, SE = 0.405, p = 0.940; p-for-interaction = 0.001). Similar group differences were found for MMSE changes (non-CMB: β = -2.365, SE = 0.566, p < 0.001; CMB: β = -0.816, SE = 0.653, p = 0.217; p-for-interaction = 0.073). Stratification by lobar CMBs confirmed significant interaction effects for both CDR-SOB (p-for-interaction = 0.007) and MMSE (p-for-interaction = 0.045) scores. Imaging analysis showed more extensive cortical atrophy in the CMB group, but tau-related cortical atrophy was widespread only in the non-CMB group and minimal in the CMB group. DISCUSSION: In the non-CMB group, tau burden was strongly associated with cognitive decline and cortical atrophy. By contrast, the CMB group exhibited greater CSVD burden and pronounced neurodegeneration not explained by tau, suggesting that additional mechanisms such as CSVD related to cerebral amyloid angiopathy or neuroinflammation may contribute to disease progression in this group.
引用
- Jung YH, Cho J, Lee SY, et al. Impact of Cerebral Microbleeds on Tau-Associated Cognitive and Structural Decline. Neurology. 2025. PMID: 41348999. doi:10.1212/WNL.0000000000214453
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。